ISRG241011C500000
- 0.30
- +0.17+130.77%
Intuitive Surgical Newsroom
RBC Capital Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $525
Intuitive Surgical Price Target Raised to $525 From $515 at RBC Capital
Robots in the usa factory are starting to "lose their jobs"...
①In the USA factory, the work left for new siasun robot&automation seems to be decreasing... ②Many business executives express that as production lines and workshop businesses slow down, manufacturers are reducing the purchase of automation equipment; ③At the same time, in the USA labor market, more human workers are queuing up to find jobs.
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $494
Buy Rating on Intuitive Surgical: Expanding Robotic Surgery Into Emergency Procedures Promises Market Growth
Is Intuitive Surgical, Inc. (NASDAQ:ISRG) The Top Goldman Sachs Fund Manager Stock Pick?
Earnings Preview: What to Expect From Intuitive Surgical's Report
We Ran A Stock Scan For Earnings Growth And Intuitive Surgical (NASDAQ:ISRG) Passed With Ease
Intuitive Surgical, Inc. (ISRG) Registers a Bigger Fall Than the Market: Important Facts to Note
Intuitive Surgical Is Maintained at In-Line by Evercore ISI Group
Intuitive Surgical Analyst Ratings
Evercore ISI Adjusts Intuitive Surgical Price Target to $475 From $410
Intuitive Surgical Stock Hits 52-week High at $496.48
Jim Cramer Prefers Intuitive Surgical, Inc. (NASDAQ:ISRG) Over Procept Biorobotics
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $550
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $550
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Teleflex (TFX)
Stocks That Are Set to Benefit From Either Harris or Trump Winning Scenarios – Barclays
Here's How Much $100 Invested In Intuitive Surgical 10 Years Ago Would Be Worth Today
Intuitive Surgical, Inc. (ISRG) Is Attracting Investor Attention: Here Is What You Should Know